Form 4: InspireMD Director Gary Roubin Acquires Shares via Warrant Exercise

InspireMD Director Gary S. Roubin acquired 30,624 shares of common stock at $1.3827 per share through the exercise of Series I Warrants, increasing his direct beneficial ownership to 567,103 shares.

Summary

• Gary S. Roubin, a Director of InspireMD, Inc. (NSPR), acquired 30,624 shares of common stock.
• The acquisition occurred on June 25, 2025, at a price of $1.3827 per share.
• This transaction was made pursuant to a Rule 10b5-1 plan.
• The shares were acquired through the exercise of Series I Warrants, which had an exercise price of $1.3827.
• Following this transaction, Roubin directly beneficially owns 567,103 shares of InspireMD, Inc. common stock.
• The Series I Warrants exercised were originally exercisable from May 15, 2023, and expire on July 23, 2025.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even through warrant exercise, generally indicates confidence in the company's future. The transaction being under a 10b5-1 plan suggests a pre-planned strategy rather than opportunistic timing, which is neutral to slightly positive. No negative information is present.

Positives

• A company director, Gary S. Roubin, increased his direct beneficial ownership in InspireMD, Inc. by acquiring 30,624 shares.
• The acquisition was executed at a price of $1.3827 per share, indicating a specific valuation at the time of the transaction.
• The transaction was conducted under a Rule 10b5-1 plan, suggesting a pre-planned and systematic approach to insider trading, which can reduce concerns about opportunistic trading.

Future Outlook

This Form 4 filing does not provide forward-looking statements or guidance; it reports a past transaction.

Industry Context

This filing reports an insider transaction, which is a routine disclosure for publicly traded companies. Insider buying can sometimes be seen as a positive signal, indicating management's confidence in the company's future prospects, especially when done via open market purchases or warrant exercises.

Comparison to Industry Standards

• This is a standard insider transaction report. There are no specific comparable companies, projects, or results mentioned within the filing to assess against global benchmarks. The transaction itself is a common occurrence in public markets.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by Gary S. Roubin, a Director of InspireMD, Inc., constitutes a related-party transaction as it involves an insider of the company.

Stakeholder Impact

• Shareholders: The acquisition by a director could be viewed positively as a sign of confidence, potentially influencing investor sentiment.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing indicates an insider (Director Gary S. Roubin) has increased his stake in InspireMD, Inc. by exercising warrants to acquire common stock. While insider buying can be a positive signal of confidence, this specific transaction is an exercise of existing warrants rather than an open market purchase, which might be less indicative of a strong 'buy' signal based on current market conditions. The transaction was also pre-planned under a Rule 10b5-1 plan. Without additional financial performance data or strategic updates, this single transaction primarily reinforces a 'hold' position, suggesting that existing investors might maintain their positions given the insider's continued commitment, but it doesn't provide a strong catalyst for new investment or divestment.

Keywords

InspireMD, NSPR, Form 4, Insider Trading, Beneficial Ownership, Director, Stock Acquisition, Warrant Exercise, Rule 10b5-1